The system provides intravenous administration of propofol for minimal-to-moderate sedation during colonoscopy and EGD procedures. The system is also approved to allow physician-led teams administer propofol, rather than requiring an anesthesiologist to perform the sedation. However, the company will offer the system to “facilities where an anesthesia professional is immediately available for assistance or consultation,” according to the release.
The SEDASYS is designed to reduce over sedation and help healthcare facilities more effectively use limited resources.
More Articles on Anesthesia:
FDA Clears Masimo’s Rainbow Respiratory Monitor for Pediatric Use
Hospira GemStar Infusion System Recalled by FDA for Battery Malfunction
Georgia-based Gwinnett Anesthesia Service Acquired by MEDNAX
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
